Compounds > amineptin
Page last updated: 2024-08-23

amineptin and phenobarbital

amineptin has been researched along with phenobarbital in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Glen, RC; Lowe, R; Mitchell, JB1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Amouyal, G; Descatoire, V; Geneve, J; Larrey, D; Letteron, P; Pessayre, D; Tinel, M1
Amouyal, G; Degott, C; Descatoire, V; Geneve, J; Larrey, D; Letteron, P; Pessayre, D; Tinel, M1

Reviews

1 review(s) available for amineptin and phenobarbital

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for amineptin and phenobarbital

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Metabolic activation of the tricyclic antidepressant amineptine--I. Cytochrome P-450-mediated in vitro covalent binding.
    Biochemical pharmacology, 1987, Feb-01, Volume: 36, Issue:3

    Topics: Animals; Antidepressive Agents, Tricyclic; Biotransformation; Cricetinae; Cytochrome P-450 Enzyme System; Dibenzocycloheptenes; Kidney; Kinetics; Lung; Male; Mesocricetus; Microsomes; Microsomes, Liver; NADP; Phenobarbital

1987
Metabolic activation of the tricyclic antidepressant amineptine--II. Protective role of glutathione against in vitro and in vivo covalent binding.
    Biochemical pharmacology, 1987, Feb-01, Volume: 36, Issue:3

    Topics: Animals; Antidepressive Agents, Tricyclic; Biotransformation; Buthionine Sulfoximine; Cricetinae; Dibenzocycloheptenes; Glutathione; Ketones; Kinetics; Male; Mesocricetus; Methionine Sulfoximine; Microsomes, Liver; NADP; Phenobarbital; Piperonyl Butoxide

1987